{"disease":{"id":"neutropenia-febrile","name":"neutropenia febrile"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04669418","title":"Host RNA Signature in Children With Cancer and Infection","phase":"","overall_status":"COMPLETED","enrollment_count":370,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06711523","title":"Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":250,"lead_sponsor_name":"Kexing Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT04101760","title":"Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT03217721","title":"Antibiotics Management of Septic Neutropenic Patients in the Intensive Care Unit","phase":"","overall_status":"COMPLETED","enrollment_count":130,"lead_sponsor_name":"University Hospital, Brest","has_results":false},{"nct_id":"NCT04637464","title":"Early Termination of Empirical Antibiotics in Febrile Neutropenia in Children With Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Kjeld Schmiegelow","has_results":false},{"nct_id":"NCT04187755","title":"Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT04938206","title":"DIStinguishing ChildrEn at Low Risk of Severe infectioN in Case of Febrile Neutropenia-7: Impact Study of a Clinical Decision Rule","phase":"NA","overall_status":"TERMINATED","enrollment_count":63,"lead_sponsor_name":"University Hospital, Lille","has_results":false},{"nct_id":"NCT03511820","title":"A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever","phase":"","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"TTY Biopharm","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}